Member Info for Bennster

Time will tell.
There is certainly some fight being put up to gain control, so the Taumanns must see something to excite them.
I hold.

given my more recent top ups my average is now 5p. Let's see on the 19th whether these conversions are safe for the long haul or sold for a quick buck.
I believe there was 11M altogether to convert if they are all taken.

Total purchases today:

£457.72 - and no that's not in £M or £'000.
It's £457.72

The public aren't really paying attention Mr Israeli, more's the pity.

I agree. Shocked with his attempts to dodge the bankruptcy charges. Lost his trophies indeed......

Well I've topped up.

The value of OBC is now simply the current SP of its share in AFN. No value attached to it's crypto or cash holdings. Assuming zero revenue too....

I'm trying to understand why this has goner ballistic today.
AFN is steady, UMBR is steady too
Easter seller, or a leak?

we'll see.
I still expect volatility as this one gets attention (and therefore attracts traders).
I'm still in ISA mode for the long term, hoping nothing derails the Frankfurt KPOP - if that delivers then we really are in for a ride.

The capital value of the AFN share has dropped a little since the board wrangles there started to settle.
The value of ETH and more pertinently UMBR drive the value here, but crypto has been shaky since the war started.
Maybe that's caused this to flatline?

I'm still here, but it's gone very quiet. We had lots of positive updates from Delferg for a while then he just disappeared.

I can only lay claim to one of the 50k trades Tintin - somebody else had the same Idea as me today :-)

I took a little top up this morning - was pleased to get below 9p

No conspiracies needed folks - there's a tonne of grey transactions which were "sells" by the spread at the time.
You'll go mad or blind or both if you read anything into the registered "buys" and "sells" - it's just automated registration of trades with a guesstimate based on the spread at the time.
I have bought these shares this year and seen them come up as "sells"....

Steve Harley and ****ney Rebel?

I assume you mean the charting dude?
A share like this with a rapidly changing business model and multiple placings isn't going to fit the chartist model.
The SP growth we will see will come from the unfolding news and not some bollinger bands.
He may be right, but that would be like the broken clock which is still right twice a day ;-)

If he advertises the company to new investors all well and good, but we don't need day traders here - that just muddies the waters. What if next week he "prophesies" that LVCG is going to drop?

Another problem with your plan Castle.
With what funds are BRH still funding the Dementia work? In truth we have had zero RNS updates on the Dementia piece because the last update on it was downbeat (as I posted below).
The company are still raising funds only last week and given their cash burn in 2021 are unlikely to have £millions floating about.
We all want to see at year end what they have actually been spending the last placing on, but it's highly likely from the RNS at the time that it was Autins and the CX300 that took what cash was in the kitty as at August 2021.

Dementia update 30th September 2021

"As planned, a prototype instrument was tested by Vrije University Medical Centre Amsterdam (VUMC), a target user of the AD Scanner, using AD patient samples. VUMC reported that the instrument performed capillary isoelectric focusing (cIEF) in a highly stable manner and showed excellent repeatability of results. However, the analysis of test results failed to reliably discriminate between patients with Alzheimer's disease and healthy controls. The cause of this result is not known, but it is clear that commercialisation of the AD Scanner in its current form is not practical and any further work will be outside the grant funded project."

another one you can hold in hope, but no more.

what update might we get before mid-May?
The last RNS spells out that longitudinal tests on the CX300 technology finish at the end of June......

So you can't answer the questions I posed.
All you've done is suggested testing at workplaces seems like a good idea to you.
NOT why the CX300 technology would be of use, why it wouldn't be any other companies technology, or how this testing fits with our nations approach to COVID.
I'm not negative or moaning. I'm a realist and I'm asking you to justify your position so we can understand if there's anything worth reading there.
I have been very open that I expect a price rise at some point around June, but it's based on Phasefocus, something you never mention or judge in your postings - as though the whole BRH world revolves around a currently fictional COVID application of CX300.

Well done Castle
You've managed to confirm what we already knew - that COVID is still about. And I have never said COVID has gone.....

Now lets move onto the tricky bit:
A) Why do you still believe that the CX300 will be used as a COVID test after the RNS Feb 25th confirming that the CX300 still has to get through more clinical trials to finish end of June and after that it will focus on Sepsis and Bladder cancer?
B) Even if the CX300 were approved for use (which it isn't yet) Why do you think that Paraytec's test would be chosen by anybody over the myriad of other tests being developed and brought to market out there?
C) Now that the UK has effectively downgraded COVID to a respiratory disease and will be treated the same as Flu, why would the rest of the West not follow suit?

In the mean time why do you not post about anything other than COVID? You are aware that BRH is actually an investment company with a number of investments and not a pharma company dedicated to a COVID test?
I await your response with interest.